Growth Metrics

Heartflow (HTFL) Accumulated Depreciation & Amortization (2024 - 2025)

Heartflow's quarterly Accumulated Depreciation & Amortization came in at $12.5 million in Q4 2025, down 75.71% year-on-year from $51.5 million in Q4 2024, and up 3452.56% quarter-over-quarter from $352000.0 in Q3 2025.

Heartflow has reported Accumulated Depreciation & Amortization for 2 years, with the latest figure at $12.5 million in Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Depreciation & Amortization fell 75.71% year-over-year to $12.5 million; the trailing twelve-month figure through Dec 2025 stood at $12.5 million (down 75.71% YoY), and the FY2025 full-year result was $12.5 million, down 75.71% from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 stood at $12.5 million, up from $352000.0 in the prior quarter.
  • The five-year high for Accumulated Depreciation & Amortization was $51.5 million in Q4 2024, with the low at $352000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn
10 Heartflow 1.15 Bn 974.90 Mn 39.06 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 12.51 Mn
Dec 31, 2025 12.51 Mn
Sep 30, 2025 352,000.00
Sep 30, 2025 352,000.00
Jun 30, 2025 389,000.00
Jun 30, 2025 389,000.00
Dec 31, 2024 51.49 Mn
Dec 31, 2024 51.49 Mn
Sep 30, 2024 3.77 Mn
Sep 30, 2024 3.77 Mn
Jun 30, 2024 2.38 Mn
Jun 30, 2024 2.38 Mn